SmartNuclide
About:
SmartNuclide is a biopharmaceutical company that develops biological drug products.
Website: https://www.smartnucl.com/
Top Investors: Alphamab Oncology, Oriza Holdings, Longmen Capital, Jiuyou Capital, Kington Capital
Description:
SmartNuclide is dedicated to the discovery, manufacture, and marketing of nuclear medicine diagnostic and therapeutic pharmaceuticals. The company established a number of research and development pathways for radiopharmaceutical medications, including recombinant proteins, imaging, and radiotherapeutic pharmaceuticals.
Total Funding Amount:
133M CNY
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2015-09-25
Contact Email:
info(AT)smartnucl.com
Founders:
Tao Xu
Number of Employees:
11-50
Last Funding Date:
2024-04-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai